DRUG EPS Estimates
Bright Minds Biosciences Inc.
$50.71
-$0.65(-1.27%)
37
Overall
60
Value
18
Tech
34
Quality
Market Cap
$497.95M
Volume
199.35K
52W Range
$47.23 - $123.75
Target Price
$154.83
DRUG EPS estimates: the consensus estimate for Bright Minds Biosciences Inc.'s current fiscal year is -$2.93 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
DRUG EPS Estimates
- EPS estimate, current quarter
- $-1.07
- EPS estimate, next quarter
- $-1.09
- EPS estimate, current year
- $-2.93
- EPS estimate, next year
- $-6.77
- EPS growth, 3-year
- +0.00%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.78 |
| 2024 | $-0.65 |
| 2023 | $-1.98 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DRUG | $50.71 | -1.3% | 199.35K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bright Minds Biosciences Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW